Back
Spyre Therapeutics Stock Price Chart
![](/images/offers/ims/large/offer9.jpg)
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
SYRE
Spyre Therapeutics
Last Price:
$22.77
Seasonality Move:
0.26%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer4.jpg)
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Spyre Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.11 | Buy |
20-day SMA: | 22.25 | Buy |
50-day SMA: | 23.66 | Sell |
200-day SMA: | 28.69 | Sell |
8-day EMA: | 22.85 | Buy |
20-day EMA: | 22.77 | Buy |
50-day EMA: | 24.07 | Sell |
200-day EMA: | 26.72 | Sell |
Spyre Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 51.9 | Buy |
Chaikin Money Flow: | 434069 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.27 - 23.39) | Buy |
Bollinger Bands (100): | (22.72 - 32.1) | Sell |
Spyre Therapeutics Technical Analysis
Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Spyre Therapeutics Stock
Is Spyre Therapeutics Stock a Buy?
-
Spyre Therapeutics share price is 23.27 while SYRE 8-day simple moving average is 23.11, which is a Buy signal.
-
The stock price of SYRE is 23.27 while Spyre Therapeutics 20-day SMA is 22.25, which makes it a Buy.
-
Spyre Therapeutics 50-day simple moving average is 23.66 while SYRE share price is 23.27, making it a Sell technically.
-
SYRE stock price is 23.27 and Spyre Therapeutics 200-day simple moving average is 28.69, creating a Sell signal.
SYRE Technical Analysis vs Fundamental Analysis
Sell
28
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy or a Sell?
-
Spyre Therapeutics stock is rated a SellThe current Spyre Therapeutics [SYRE] share price is $23.27. The Score for SYRE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Spyre Therapeutics Stock Info
Market Cap:
1.4B
Price in USD:
23.27
Share Volume:
467.8K
Spyre Therapeutics 52-Week Range
52-Week High:
47.97
52-Week Low:
20.07
Sell
28
Spyre Therapeutics (SYRE)
is a Sell
Spyre Therapeutics Share Price Forecast
-
What is the Spyre Therapeutics stock price today?The Spyre Therapeutics stock price is 23.27 USD today.
-
Will SYRE stock go up or go down?Spyre Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Spyre Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spyre Therapeutics is overvalued.
Is Spyre Therapeutics Stock a Buy?
-
Spyre Therapeutics share price is 23.27 while SYRE 8-day exponential moving average is 22.85, which is a Buy signal.
-
The stock price of SYRE is 23.27 while Spyre Therapeutics 20-day EMA is 22.77, which makes it a Buy.
-
Spyre Therapeutics 50-day exponential moving average is 24.07 while SYRE share price is 23.27, making it a Sell technically.
-
SYRE stock price is 23.27 and Spyre Therapeutics 200-day simple moving average is 26.72, creating a Sell signal.
Fundamental Analysis of Spyre Therapeutics
Is Spyre Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $1.17 per share.
Technical Analysis of Spyre Therapeutics
Should I short Spyre Therapeutics stock?
-
SYRE Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Spyre Therapeutics is a Sell
-
Spyre Therapeutics Relative Strength Index (RSI) is 51.9, which suggest Spyre Therapeutics is overbought
-
The Bollinger Bands (25) for Spyre Therapeutics is (21.27 - 23.39), which suggest Spyre Therapeutics is a Sell
-
The Bollinger Bands (100) for Spyre Therapeutics is (22.72 - 32.1), which suggest Spyre Therapeutics is a Sell
* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.